We consider a sequence of multinomial data for which the probabilities associated with the categories are subject to abrupt changes of unknown magnitudes at unknown locations. When the number of categories is comparable to or even larger than the number of subjects allocated to these categories, conventional methods such as the classical Pearson's chi-squared test and the deviance test may not work well. Motivated by high-dimensional homogeneity tests, we propose a novel change-point detection procedure that allows the number of categories to tend to infinity. The null distribution of our test statistic is asymptotically normal and the test performs well with finite samples. The number of change-points is determined by minimizing a penalized objective function based on segmentation, and the locations of the change-points are estimated by minimizing the objective function with the dynamic programming algorithm. Under some mild conditions, the consistency of the estimators of multiple change-points is established. Simulation studies show that the proposed method performs satisfactorily for identifying change-points in terms of power and estimation accuracy, and it is illustrated with an analysis of a real data set.
A new criterion is proposed in this paper which employs the grayscale erosion to measure the concentration of different time-frequency representations/distributions. In contrast to some widely used Concentration Measures proposed by L.Stankovic and L.Jones, this method combines the both width and peakedness information of the auto-term area. Moreover, it can be used in the multi-component signal analysis when the minimum mean square error criterion is invalid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.